Literature DB >> 6184771

Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.

L Ekerot, K Ohlsson.   

Abstract

Paired plasma and synovial fluids from 17 patients with seropositive rheumatoid arthritis were examined for electrophoretic homogeneity/heterogeneity and enzymic inhibitory capacity of the protease inhibitors. The high degree of saturation (approximately 90%) of the polyvalent protease inhibitor alpha 2-macroglobulin in the rheumatoid synovial fluid contrasts sharply with the low saturation of alpha 1-anti-trypsin. The inhibitory reactivity of the non-complexed fraction of both of these dominating antiproteases was retained (approximately 85-90%). Thus, a selective inactivation of synovial alpha 1-antitrypsin could not be demonstrated. alpha 1-Anti-chymotrypsin revealed electrophoretic homogeneity in all synovial fluids. Electrophoretic heterogeneity of the plasmin inhibitor antiplasmin was detected in the majority of synovial fluids indicating plasmin activation. The existence of a protease-antiprotease imbalance in the rheumatoid joint was indicated by the high degree of saturation of alpha 2-macroglobulin and a cleavage of C3 in rheumatoid synovial fluids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184771     DOI: 10.1007/bf00541266

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Proteinase inhibitors in rheumatoid arthritis.

Authors:  D Brackertz; J Hagmann; F Kueppers
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

2.  The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes.

Authors:  K Ohlsson; I Olsson
Journal:  Scand J Haematol       Date:  1977-08

3.  Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin.

Authors:  K Ohlsson; D Collen
Journal:  Scand J Clin Lab Invest       Date:  1977-06       Impact factor: 1.713

4.  The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1973-07-16

5.  The synthesis and analytical use of a highly sensitive and convenient substrate of elastase.

Authors:  J Bieth; B Spiess; C G Wermuth
Journal:  Biochem Med       Date:  1974-12

6.  Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases.

Authors:  W Pruzanski; M L Russell; D A Gordon; M A Ogryzlo
Journal:  Am J Med Sci       Date:  1973-06       Impact factor: 2.378

7.  Neutral proteases of human granulocytes. IV. Interaction between human granulocyte collagenase and plasma protease inhibitors.

Authors:  K Ohlsson; I Olsson
Journal:  J Lab Clin Med       Date:  1977-02

8.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.

Authors:  L H Perrin; U E Nydegger; R H Zubler; P H Lambert; P A Miescher
Journal:  Arthritis Rheum       Date:  1977-03

10.  alpha1-Antichymotrypsin interaction with cationic proteins from granulocytes.

Authors:  K Ohlsson; U Akesson
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

View more
  1 in total

1.  Identification of α1-Antitrypsin as a Potential Candidate for Internal Control for Human Synovial Fluid in Western Blot.

Authors:  Shaowei Wang; Jingming Zhou; Xiaochun Wei; Pengcui Li; Kai Li; Dongming Wang; Fangyuan Wei; Jianzhong Zhang; Lei Wei
Journal:  Rheumatology (Sunnyvale)       Date:  2015-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.